RE:A look back and a look forward! Great summary of the recent (and future) direction of THRM, Scientist. I would only add that Step 9 may happen more quickly with an EUA authorization by the FDA. Your summary fits incredibly well with the analyses where Morningstar's Fair Value sp is over $.70 and the 1-star valuation over $4.00. The sentiment from Barchart is still a very positive 72% BUY.
It's unfortunate that the markets in North America can be so easily manipulated particularly when there are low volumes. The volatility (bleeding) of these same markets over the last two months no doubt tests the resolve of many investors. As you have so aptly expressed that doesn't change reality .....AcuVid appears to be all that it was designed to be and quite possibly more.
Cheers and GLTE ....patiently holding long.